These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2104189)

  • 1. Cytokines in the pathophysiology of systemic lupus erythematosus.
    Goldman M
    Autoimmunity; 1990; 8(2):173-9. PubMed ID: 2104189
    [No Abstract]   [Full Text] [Related]  

  • 2. Cytokine regulation of apoptosis and Bcl-2 expression in lymphocytes of patients with systemic lupus erythematosus.
    Graninger WB; Steiner CW; Graninger MT; Aringer M; Smolen JS
    Cell Death Differ; 2000 Oct; 7(10):966-72. PubMed ID: 11279543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of physiologic B cell responses and B cell hyperactivity in systemic lupus erythematosus.
    Zubler RH; Huang YP; Miescher PA
    Springer Semin Immunopathol; 1986; 9(2-3):195-218. PubMed ID: 2949381
    [No Abstract]   [Full Text] [Related]  

  • 4. Cytokine-independent progression of immunoglobulin production in vitro by B lymphocytes from patients with systemic lupus erythematosus.
    Pelton BK; Speckmaier M; Hylton W; Farrant J; Denman AM
    Clin Exp Immunol; 1991 Feb; 83(2):274-9. PubMed ID: 1825187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The roles of interleukin-6 and interleukin-10 in B cell hyperactivity in systemic lupus erythematosus.
    Cross JT; Benton HP
    Inflamm Res; 1999 May; 48(5):255-61. PubMed ID: 10391113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Increased immune reactivity in systemic lupus erythematosus. III. Different in vitro stimulation of lymphocytic populations by mitogenic serum factors (author's transl)].
    Günther W; Diezel W; Meffert H; Sönnichsen N
    Dermatol Monatsschr; 1978 Oct; 164(10):711-4. PubMed ID: 310779
    [No Abstract]   [Full Text] [Related]  

  • 7. Immune cells and cytokines in systemic lupus erythematosus: an update.
    Kyttaris VC; Juang YT; Tsokos GC
    Curr Opin Rheumatol; 2005 Sep; 17(5):518-22. PubMed ID: 16093827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B cell hyperactivity is a function of T cell derived cytokines in systemic lupus erythematosus.
    al-Janadi M; Raziuddin S
    J Rheumatol; 1993 Nov; 20(11):1885-91. PubMed ID: 7508509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New fields of cyclosporin A (sandimmun) application in rheumatology: treatment of systemic lupus erythematosus].
    Nasonov EL; Kliukvina NG; Shekshina SV; Nasonova VA
    Ter Arkh; 2000; 72(5):67-71. PubMed ID: 11109628
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of systemic lupus erythematosus: new advances in targeted therapy.
    Lo MS; Tsokos GC
    Ann N Y Acad Sci; 2012 Jan; 1247():138-52. PubMed ID: 22236448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Interleukin 2 receptor positive B cells and its responsiveness to human recombinant interleukin 2 in patients with systemic lupus erythematosus].
    Matsumoto Y; Itoh A
    Rinsho Byori; 1987 Jun; 35(6):679-83. PubMed ID: 3118081
    [No Abstract]   [Full Text] [Related]  

  • 12. Recent advances in cytokines in cutaneous and systemic lupus erythematosus.
    Mikita N; Ikeda T; Ishiguro M; Furukawa F
    J Dermatol; 2011 Sep; 38(9):839-49. PubMed ID: 21767292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of interleukins in autoimmunity].
    Fradelizi D; Harel-Bellan A; Chatenoud L
    Presse Med; 1984 Mar; 13(12):713-5. PubMed ID: 6231574
    [No Abstract]   [Full Text] [Related]  

  • 14. Do cytokines play a role in systemic lupus erythematosus?
    Singh AK
    J R Coll Physicians Lond; 1992 Oct; 26(4):374-6. PubMed ID: 1432876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of inflammatory markers associated with systemic lupus erythematosus patients undergoing treatment.
    Timóteo RP; Micheli DC; Teodoro RB; Freire M; Bertoncello D; Murta EF; Tavares-Murta BM
    Rev Bras Reumatol Engl Ed; 2016; 56(6):497-503. PubMed ID: 27914596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cytokines and lupus].
    Emilie D; Llorente L; Galanaud P
    Ann Med Interne (Paris); 1996; 147(7):480-4. PubMed ID: 9092358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Physiopathology of systemic lupus erythematosus].
    Sakane T
    Nihon Naika Gakkai Zasshi; 1992 Sep; 81(9):1509-13. PubMed ID: 1453074
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunopathological roles of cytokines, chemokines, signaling molecules, and pattern-recognition receptors in systemic lupus erythematosus.
    Yu SL; Kuan WP; Wong CK; Li EK; Tam LS
    Clin Dev Immunol; 2012; 2012():715190. PubMed ID: 22312407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Etiopathogenesis of systemic lupus erythematosus].
    Mathian A
    Rev Med Interne; 2007 Dec; 28 Suppl 4():S298-301. PubMed ID: 17964004
    [No Abstract]   [Full Text] [Related]  

  • 20. Disease severity in patients with systemic lupus erythematosus correlates with an increased ratio of interleukin-10:interferon-gamma-secreting cells in the peripheral blood.
    Hagiwara E; Gourley MF; Lee S; Klinman DK
    Arthritis Rheum; 1996 Mar; 39(3):379-85. PubMed ID: 8607886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.